Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01669525 · ClinicalTrials.gov registry record
Placental Growth and Adverse Pregnancy Outcomes
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 1,043
- Enrollment target
NCT01669525: Completed study, sponsored by University of Pennsylvania.
NCT01669525 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 1,043 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01669525 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 1,043 participants
- Enrollment target
Study Summary
The purpose of this study to determine if measurement of maternal serum biomarkers and evaluation of the placenta by ultrasound can improve prediction of adverse pregnancy outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,043 participants |
| Start Date | 2009-11 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01669525
The ClinicalTrials.gov registry entry for NCT01669525 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,043 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01669525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01669525 about?
NCT01669525 is a clinical study titled "Placental Growth and Adverse Pregnancy Outcomes". The purpose of this study to determine if measurement of maternal serum biomarkers and evaluation of the placenta by ultrasound can improve prediction of adverse pregnancy outcomes.
What is the current status of trial NCT01669525?
This trial is currently completed. The enrollment target is 1,043 participants. The study started on 2009-11. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT01669525?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.